Latest News Archive
Please select Category, Year, and then Month to display items
The closing date for the submission of nominations for five members of the Convocation to the Excom of the Convocation was 18 May 2020 at 16:30. A total of six nominations were received and scrutinised, after which two nominations were declared invalid due to substantial non-conformance with the requirements laid down. The remaining four candidates are thus elected to the Excom and will serve for a period not exceeding five years.
We wish to congratulate the following four officials (in alphabetical order) with their election to the Excom of the Convocation:
1. Dr Pieter Bettings
2. Ms Ntombi Nhlapo
3. Mr Ntakuseni Razwiedani
4. Ms Nokuthula Sithole
A meeting of the Excom of the Convocation will be scheduled to discuss the one remaining vacancy in the Excom.
We wish to express our sincere gratitude to all those who participated in this process as well for their interest in, and commitment to the University and its affairs.
Received from: The Registrar and the President of the Convocation
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology